One out of every 80 women can develop ovarian cancer at some point in their life. So, how is hot chemotherapy treatment applied in ovarian cancer?
“One out of every 80 women can have ovarian cancer at some point in their life. 70 to 80 percent of ovarian cancer patients are diagnosed at an advanced stage. Because ovarian masses do not cause complaints unless they turn around and cause pain or spread and create fluid in the abdomen. undetectable.”
Stating that it has been determined that patients who receive hot chemotherapy in the treatment of ovarian cancer live an average of 16 months longer than those who do not, Gynecological Oncology and Gynecology Specialist Assoc. Dr. İlker Kahramanoğlu gave important information about the treatment.
“ONE OF THE SYMPTOMS OF GAS AGAINST”
Fluid accumulating in the abdomen can lead to abdominal distension and even weight gain after a certain point. In addition, almost everyone can develop ambiguous digestive system complaints from time to time, such as constipation and gas pains in ovarian cancer.
IT IS IMPORTANT THAT THERE IS NO TUMOR IN THE SURGERY
The most important factor determining survival in ovarian cancer is the quality of surgery (whether or not the tumor remains) and the response to chemotherapy. When choosing the center and surgeon where the patients will be operated, they should pay attention to the rate of tumor failure in the surgery. This success is achieved in 45-80 of 100 patients in the world’s leading centers. In our series, we achieve tumor-free success in 78 percent of our patients. Ovarian cancer surgeries, which are performed to prevent the tumor from remaining, can take up to 8-9 hours.
“HIGH SUCCESS WITH HOT CHEMOTHERAPY”
Hot chemotherapy is a treatment method in which chemotherapy drugs heated to approximately 42 degrees Celsius are applied to the abdominal cavity after the tumor removal procedures are completed in ovarian cancer (ovarian cancer) surgery in suitable patients. The underlying rationale for this is that the heated drug penetrates deeper into microscopic tumor cells and has a greater cytotoxic, i.e., tumor cell-killing effect. It has not yet switched to standard treatment in ovarian cancer, but based on the results of two important clinical studies and our own experience, we can recommend hot chemotherapy in a certain group of patients. Under experienced hands, the risks that will develop after surgery due to hot chemotherapy are minimal.